These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 6306333)
1. Converting enzyme activity and essential hypertension. Overlack A; Higuchi M; Kolloch R; Stumpe KO Klin Wochenschr; 1983 Apr; 61(7):377-8. PubMed ID: 6306333 [TBL] [Abstract][Full Text] [Related]
2. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels. Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579 [TBL] [Abstract][Full Text] [Related]
3. Captopril normalises systolic blood pressure in rats with hypertension induced by fetal exposure to maternal low protein diets. Langley-Evans SC; Jackson AA Comp Biochem Physiol A Physiol; 1995 Mar; 110(3):223-8. PubMed ID: 7712066 [TBL] [Abstract][Full Text] [Related]
4. Comparison of sublingual and oral captopril in hypertension. Dessì-Fulgheri P; Bandiera F; Rubattu S; Cocco F; Madeddu P; Oppes M; Tonolo GC; Glorioso N; Rappelli A Clin Exp Hypertens A; 1987; 9(2-3):593-7. PubMed ID: 3038422 [TBL] [Abstract][Full Text] [Related]
5. Fluctuations in the plasma angiotensin I converting enzyme activity during long-term treatment with captopril. Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A Acta Cardiol; 1982; 37(1):1-9. PubMed ID: 6282024 [TBL] [Abstract][Full Text] [Related]
6. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin I-converting enzyme gene polymorphism and acute response to captopril in essential hypertension. Nakano Y; Oshima T; Watanabe M; Matsuura H; Kajiyama G; Kambe M Am J Hypertens; 1997 Sep; 10(9 Pt 1):1064-8. PubMed ID: 9324115 [TBL] [Abstract][Full Text] [Related]
8. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects. Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782 [TBL] [Abstract][Full Text] [Related]
9. [The effect of alterations of the renin-angiotensin system and the sympathetic nervous system on plasma bradykinin concentration in patients with essential hypertension]. Takeda Y Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1112-24. PubMed ID: 6097486 [TBL] [Abstract][Full Text] [Related]
11. [Antihypertensive mechanism of oral angiotensin I converting enzyme inhibitor (captopril) in renin-independent essential hypertension]. Miyamori I; Takeda Y; Ikeda M; Koshida H; Yasuhara S; Morise T; Takimoto H; Takeda R; Nishino T Nihon Naibunpi Gakkai Zasshi; 1983 Jun; 59(6):907-17. PubMed ID: 6311635 [TBL] [Abstract][Full Text] [Related]
12. Effect of captopril on serum angiotensin converting enzyme and blood pressure in hypertensive patients. Singh R; Kalra OP; Sarma PU; Prabhu KM J Assoc Physicians India; 1996 Feb; 44(2):109-11. PubMed ID: 10999062 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-I converting enzyme activity in the sera of captopril-treated hypertensive patients. Rosenthal T; Holtzman E; Yaron A Clin Exp Hypertens A; 1982; 4(3):367-77. PubMed ID: 6280902 [TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women. Umeda M; Ichikawa S; Kanda T; Sumino H; Kobayashi I Am J Hypertens; 2001 Mar; 14(3):206-11. PubMed ID: 11281230 [TBL] [Abstract][Full Text] [Related]
15. Kinetic studies of the pharmacologic response to captopril in rats. II. Hypotensive effect and plasma angiotensin converting enzyme activity. Endoh M; Suzuki M; Katayama K; Kakemi M; Koizumi T J Pharmacobiodyn; 1989 Jan; 12(1):10-7. PubMed ID: 2542517 [TBL] [Abstract][Full Text] [Related]
16. Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension. Mondorf UF; Russ A; Wiesemann A; Herrero M; Oremek G; Lenz T Am J Hypertens; 1998 Feb; 11(2):174-83. PubMed ID: 9524045 [TBL] [Abstract][Full Text] [Related]
17. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned? Erman A; Boner G; van Dijk DJ J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825 [TBL] [Abstract][Full Text] [Related]
18. [The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril]. Jiang M Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):342-4, 396. PubMed ID: 1668233 [TBL] [Abstract][Full Text] [Related]
19. Responses of blood pressure and angiotensin-converting enzyme activity to acute captopril administration in normotensive and hypertensive rats. Levens NR; Peach MJ; Vaughan ED; Weed WC; Carey RM Endocrinology; 1981 Feb; 108(2):536-44. PubMed ID: 6256155 [TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of serum angiotensin I-converting enzyme in essential hypertension]. Gotoh M Nihon Naibunpi Gakkai Zasshi; 1985 Dec; 61(12):1341-57. PubMed ID: 3005063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]